Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...

Cancer cells that detach from a primary tumor can remain hidden in the body for years in a dormant state, avoiding immune ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...

A recent study has analyzed the relationship between different air pollutants and the main subtypes of lung cancer.

Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...